White matter changes in patients with Friedreich ataxia after treatment with erythropoietin

BACKGROUND AND PURPOSE: Erythropoietin (EPO) has received growing attention because of its neuro-regenerative properties. Preclinical and clinical evidence supports its therapeutic potential in brain conditions like stroke, multiple sclerosis and schizophrenia. Also in Friedreich ataxia, clinical im...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Egger, Karl, Clemm von Hohenberg, Christian, Schocke, Michael F, Guttmann, Charles RG, Wassermann, Demian, Wigand, Marlene C, Nachbauer, Wolfgang, Kremser, Christian, Sturm, Brigitte, Scheiber-Mojdehkar, Barbara, Kubicki, Marek, Shenton, Martha E, Boesch, Sylvia
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950637/
https://ncbi.nlm.nih.gov/pubmed/24015771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jon.12050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados